Release Summary

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary Lupin Pharmaceuticals, Inc. (LPI) has received final approval for its Armodafinil Tablets 50 mg, 150 mg, 200 mg and 250 mg

Lupin Limited